Arginine Deiminase (ADI)->anticancer pharmaceuticals

Join

Help

Protgen Ltd.

	Recommended Results

Arginine Deiminase (ADI)

Category :

Chemicals->Pharmaceutical->drug->anticancer pharmaceuticals

Product Specification

Brand

protgen

Product Detail

Arginine Deiminase, Mycoplasma Hominis,
Recombinant (rADI)
CAT. NO. 010401
Liquid. In PBS Buffer.

Arginine deiminase is a ~46 kDa protein that was isolated from the mycoplasma-contaminated cell culture. ADI can degrade arginine to citrulline and NHB3B. rADI has acted as a potent inhibitor of the growth of some arginine-dependent tumor in vitro and in vivo. rADI is expressed in E. coli and purified via Q-sepharose column.

Activity: The activity is assayed on anti-tumor cell in vitro.

Purity: more than 95 percent by SDS-PAGE.
M.W.: 46260
Ref.: Harasawa, R., et al. 1992. Microbiol. Immunol. 36, 661-665

250 ug 2000
2.5 mg 12000
12.5 mg 40000

More Products from this Supplier

Vascular Endothelial Growth Factor 165

Endostatin


[ Back Products Catalog ]

Commerce Member:
Please log in your ID and password, we will later fill in relating info.

ID:

Password:

Remember my ID on this computer


	Complete this form below to send out your enquiries. All enquiries will be automatically sent to the company you want to develop.

	Subject
	Content	(Don't input Company Name, E-Mail, Phone Number, Fax Number, and URL)

Company Profile:

* Company Name

*E-mail

*Country

*Contact Person

URL

*Phone

- -

Fax

- -

*Postal code

*City

*Street Address

*Business Nature

Distributor Exporter Importer Manufacturer
Whole Sale Retailer Reseller Retrofitter User
Others, please specify:

*Security Code


Enter the security code.